These biotech stocks are getting hammered by shocking brittle-bone
treatment study results
-
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs
after disappointing trial results for setrusumab.
55 minutes ago





ReplyDeleteEMPATHY indeed is most sympathetic SPIRITUALLY ; REALISTICALLY, Virtualization and REALIZATION are not the same, ABSOLUTELY ! THE FIGHT FOR RIGHTS ! Resolution is the SOLUTION within RATIONAL exuberance is the only way to overshadow IRRATIONAL EXUBERANCE ! ==== http://youtu.be/o8DWuHvSjYc